The FDA approved obecabtagene autoleucel for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.

Dx: diagnosis, BM: bone marrow, FC: flow cytometry, AMML: acute myelomonocytic leukemia. By the fourth day, peripheral blood flow cytometry provided an immunophenotypic diagnosis of acute ...

Hairy-cell leukemia, a chronic B-cell leukemia ... and treponemal infections and acute hepatitis. Flow cytometry, infectious studies, and imaging of the chest, abdomen, and pelvis may suggest ...

PeCan-Seq enables sensitive, non-invasive ctDNA analysis for pediatric cancers, with high accuracy for hematologic ...

The Leukemia & Lymphoma Society (LLS) will present new data from its Beat AML® Master Clinical Trial and Pediatric Acute Leukemia (PedAL) ...

Opens in a new tab or window The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine ...

Expert Rev Hematol. 2012;5(4):395-407. AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia; CBF: Core-binding factor; CEBPA-DM: CCAAT enhancer-binding protein-α with double mutation ...

The basis of peptide vaccination is the observation that leukemia cells can act as antigen-presenting cells (APCs) that cleave endogenous leukemia antigens in their proteasome and present them on ...

Hematologic oncologist Eytan Stein (shown here with nurse practitioner Coleen Ranaghan) has led the development of several new drugs for acute myeloid leukemia. Acute myeloid leukemia (AML) is one of ...